Covestor’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Buy
+2
New +$195 ﹤0.01% 2293
2026
Q1
– Sell
-202
Closed -$3K – 2205
2025
Q4
$3K Buy
202
+1
+0.5% +$19 ﹤0.01% 1865
2025
Q3
$5K Buy
201
+133
+196% +$5.02K ﹤0.01% 1842
2025
Q2
$4K Sell
68
-57
-46% -$4.57K ﹤0.01% 1762
2025
Q1
$13K Buy
125
+1
+0.8% +$87 0.01% 1331
2024
Q4
$6K Buy
124
+61
+97% +$3.69K ﹤0.01% 1687
2024
Q3
$6K Hold
63
– – ﹤0.01% 1703
2024
Q2
$10K Hold
63
– – 0.01% 1512
2024
Q1
$10K Sell
63
-79
-56% -$13.1K 0.01% 1560
2023
Q4
$45K Sell
142
-94
-40% -$34K 0.03% 893
2023
Q3
$105K Buy
236
+221
+1,473% +$100K 0.08% 387
2023
Q2
$7K Sell
15
-7
-32% -$3.93K 0.01% 1617
2023
Q1
$13K Hold
22
– – 0.01% 1172
2022
Q4
$9K Hold
22
– – 0.01% 1355
2022
Q3
$13K Sell
22
-1
-4% -$599 0.01% 1142
2022
Q2
$12K Hold
23
– – 0.01% 1135
2022
Q1
$14K Buy
23
+11
+92% +$5.67K 0.01% 1174
2021
Q4
$8K Buy
+12
New +$7.3K 0.01% 1078

Other funds holding AGL

Covestor's AGL Position: Q3 2026 in Review

Covestor opened a new position in Agilon Health (AGL) in Q3 2026: 2 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #2293 among its holdings. This is a return to the name: Covestor previously reported a position in AGL as recently as Q4 2025.

Covestor first reported a position in AGL in Q4 2021 and has held it in 18 quarters since. The position peaked at $105K in Q3 2023. 133 funds tracked by Wall St. Rank hold AGL as of Q3 2026.

  • Covestor held 2 shares of Agilon Health worth $0 as of Q3 2026.
  • Agilon Health was a new Covestor position in Q3 2026.
  • Agilon Health made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2293 holding.
  • Covestor first reported a position in Agilon Health in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Agilon Health position peaked at $105K in Q3 2023.
  • 133 funds tracked by Wall St. Rank held Agilon Health as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.